LYNGE, DENMARK – WSA today announced results for the financial year 2024/25 (October 1, 2024 – September 30, 2025) showing flat organic revenue growth and an EBITDA margin improvement of 1 %-point in line with revised guidance.
Jan Mäkelä
“The financial year 2024/25 was impacted by a decline in market growth due to macroeconomic weaknesses,” said Jan Mäkelä, CEO of WSA. “In some of our larger markets, consumers postponed hearing care treatment via the professional channel due to uncertainty about the economic outlook. In the U.S., our Managed Care business was impacted by health plans scaling back of benefit plans. Our online business continued to experience significant growth. Although revenue was lower than anticipated at the beginning of the financial year, we are satisfied that the EBITDA margin improved in line with our initial guidance. I would like to thank our dedicated WSA colleagues for their unwavering focus on pioneering innovation and helping many more people to regain the joy of hearing.”
“We continued to invest in innovation and together, we expanded the Signia IX portfolio, ensuring more voices are heard with confidence in noisy group conversations. We launched the Widex Allure platform, which sets a new standard for natural sound, as well as the world’s first cloud-based fitting software, Compass Cloud, that evolves continuously to support professionals in delivering more personalized care. The long-term outlook for the hearing aid industry remains compelling and WSA is well-positioned for strong profitable growth in the future.”
–Jan Mäkelä, CEO of WSA
Full-Year 2024/25 Highlights
- WSA reported organic revenue growth of 0% (compared to 10% last year), reaching EUR 2,579 million (~$2.8 billion USD). The company cited broader economic slowdowns and reduced benefit coverage in U.S. Managed Care as contributing factors.
- Regional performance varied: the Americas saw slower-than-expected growth, with gains in Latin America partly offsetting U.S. softness; Germany supported growth in EMEA, while France showed limited benefit from the RAC0 renewal; APAC growth was strong in Japan and South Korea but moderated in China and Australia/New Zealand.
- Consumer-facing segments delivered mixed results. Retail showed steady growth, and the Online segment performed strongly. U.S. Managed Care continued to experience pressure from scaled-back health plan benefits.
- EBITDA before special items totaled EUR 456 million (~$495 million USD), yielding a margin of 17.7%—a one-percentage-point improvement driven in part by cost controls.
- WSA invested more than EUR 170 million (~$184 million USD) in innovation during the year. Product introductions included Signia Insio Charge&Go CIC IX, Motion Charge&Go IX, and Pure Charge&Go BCT IX, along with the WIDEX ALLURE™ platform and Widex Compass Cloud fitting software.
Q4 2024/25 Highlights
- Fourth-quarter revenue reached EUR 621 million (~$673 million USD), reflecting -1% organic growth compared to a strong prior-year quarter. Market softness in several regions was partly balanced by continued momentum in Online sales.
- Q4 EBITDA before special items was EUR 119 million (~$129 million USD), corresponding to a 19.2% margin.
Outlook for Fiscal Year 2025/26
For the upcoming financial year, WSA expects organic revenue growth between 0% and 4%. The company noted that macroeconomic uncertainty continues to influence market conditions.
EBITDA margin is projected to increase by around one percentage point over 2024/25, supported by cost efficiencies and operational improvements implemented during the past year.
WSA’s Annual Report 2024/25 and Sustainability Statement are available through the company’s website.
About WS Audiology
WSA is a leading global pure-play hearing healthcare group, pioneering innovative technologies for over 140 years, helping millions of people with hearing loss regain their hearing, engage in meaningful conversations, and participate fully in society. WSA operates in over 130 markets and employs more than 12,500 people across our innovative brand platforms, Widex and Signia, and a global network of hearing care professionals and consumer-facing businesses. WSA is privately owned by the Tøpholm and Westermann families, the Lundbeck Foundation, EQT and ATHOS KG.
Source: WSA
